Peter Boström
peter.bostrom@utu.fi |
- Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study (2025)
- BJU International
- Nalidixic acid-a good marker of fluoroquinolone resistance mechanisms in Escherichia coli (2025)
- Microbiology spectrum
- Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes (2025)
- Cancers
- Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer (2025)
- European Journal of Nuclear Medicine and Molecular Imaging
- Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)
- European Urology Open Science
- Time to abandon routine urine analysis prior to Bacillus Calmette–Guérin administration in asymptomatic patients (2025)
- BJUI COMPASS
- 1H-NMR-based urine metabolomics of prostate cancer and benign prostatic hyperplasia (2024)
- Heliyon
- An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy (2024)
- Prostate Cancer and Prostatic Diseases
- Differences in Gut Microbiota Profiles and Microbiota Steroid Hormone Biosynthesis in Men with and Without Prostate Cancer (2024)
- European Urology Open Science
- Kiveksen kasvaimet (2024) Kirurgia Boström, Peter; Hemminki, Otto; Seikkula, Heikki



